Abstract
<p indent="0mm">Hypertension is one of the major risk factors for cardiovascular and cerebrovascular diseases. However, the molecular and pathological mechanism of hypertension remains unclear. Recent studies suggest that immune cell activation is involved in the development of hypertension, and chronic low-grade inflammation induces vascular dysfunction and related diseases. The complement pathway, as an important regulator of the immune system, plays a critical role in recruiting immune cells, regulating inflammation and inflammatory factors release. Abnormal activation of complement pathway and up-regulation of complement molecules are involved in the process of hypertension-related cardiovascular diseases. We herein mainly review the role of complement pathway in hypertension and related target organ damage, and propose a potential target for translational research in cardiovascular immunology.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
